Security key
74006W207
Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX)
CUSIP: 74006W207
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 27,828,540
- Total 13F shares
- 23,362,159
- Share change
- +1,933,860
- Total reported value
- $886,031,367
- Put/Call ratio
- 120%
- Price per share
- $37.87
- Number of holders
- 147
- Value change
- +$1,335,704
- Number of buys
- 79
- Number of sells
- 96
Report period
Q1 2025
Institutions
147
Top holders
10
PRAX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Praxis Precision Medicines, Inc. SEC filings
Praxis Precision Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74006W207
Recent filing periods:
Top shareholders of PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
|
Company |
6.1%
|
1,693,219
|
$130,310,134 | — | 31 Dec 2024 | |
| Clarus Lifesciences III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,894,109
|
$123,282,606 | — | 12 May 2021 | |
| BlackRock, Inc. |
13F
|
Company |
5.3%
|
1,462,445
|
$112,549,769 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.8%
|
1,329,735
|
$102,336,406 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.3%
|
1,208,522
|
$93,008,000 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
4.2%
|
1,163,526
|
$89,545,035 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
1,063,639
|
$81,857,658 | — | 31 Dec 2024 | |
| Capital Research Global Investors |
13F
13D/G
|
Company |
4.2%
from 13D/G
|
993,569
|
$76,465,070 | — | 31 Dec 2024 | |
| VR Adviser, LLC |
13F
|
Company |
3.6%
|
989,985
|
$76,189,246 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.3%
|
929,523
|
$71,620,795 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
768,655
|
$59,155,689 | — | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.7%
|
761,955
|
$58,640,057 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.2%
|
605,010
|
$46,561,570 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2%
|
559,082
|
$43,026,951 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.9%
|
521,273
|
$40,117,170 | — | 31 Dec 2024 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
4.9%
|
1,016,497
|
$37,813,688 | -$6,466,960 | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
1.7%
|
464,508
|
$35,748,536 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
406,711
|
$31,307,885 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
389,835
|
$30,001,702 | — | 31 Dec 2024 | |
| CIBC Asset Management Inc |
13F
|
Company |
1.3%
|
366,756
|
$28,225,542 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
331,533
|
$25,514,780 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
306,911
|
$23,619,870 | — | 31 Dec 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.1%
|
303,000
|
$23,318,880 | — | 31 Dec 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.1%
|
300,000
|
$23,088,000 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
279,395
|
$21,502,239 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.88%
|
243,540
|
$18,742,838 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.81%
|
226,788
|
$17,453,604 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.68%
|
188,367
|
$14,496,724 | — | 31 Dec 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.61%
|
170,000
|
$13,083,200 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
167,590
|
$12,897,726 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.59%
|
164,912
|
$12,691,628 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.57%
|
157,925
|
$12,153,908 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.54%
|
150,892
|
$11,612,648 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
142,892
|
$10,996,968 | — | 31 Dec 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.48%
|
134,178
|
$10,326,339 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.43%
|
120,267
|
$9,255,748 | — | 31 Dec 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.43%
|
119,509
|
$9,197,413 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.43%
|
118,900
|
$9,150,544 | — | 31 Dec 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.42%
|
117,970
|
$9,078,971 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
116,062
|
$8,932,132 | — | 31 Dec 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.35%
|
98,617
|
$7,589,564 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.34%
|
95,047
|
$7,314,817 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.33%
|
93,190
|
$7,171,903 | — | 31 Dec 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.33%
|
91,583
|
$7,048,228 | — | 31 Dec 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.32%
|
89,613
|
$6,896,616 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.31%
|
86,983
|
$6,694,211 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.28%
|
78,627
|
$6,051,134 | — | 31 Dec 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
72,516
|
$5,580,831 | — | 31 Dec 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.24%
|
67,500
|
$5,194,800 | — | 31 Dec 2024 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
0.24%
|
65,933
|
$5,074,204 | — | 31 Dec 2024 |
Institutional Holders of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) as of Q1 2025
As of 31 Mar 2025,
Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) was held by
147 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,362,159 shares.
The largest 10 holders included
Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, BlackRock, Inc., MORGAN STANLEY, Soleus Capital Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, VR ADVISER, LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
148
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
160
Q1 2025 holders
147
Holder diff
-13
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.